文献速递儿科与产科急症

早产儿成年者及早产儿父母对预防性使用环氧合酶抑制剂药物的健康相关价值观与偏好评估

Evaluation of Health-Related Values and Preferences of Adults Who Were Preterm Infants and Parents of Preterm Infants Concerning Use of Prophylactic Cyclooxygenase Inhibitor Drugs.
PubMed 文献 · JAMA Netw Open · 2023-03-01
一句话结论早产儿成年者及父母最看重死亡和严重脑室内出血,多数愿意考虑预防性吲哚美辛或布洛芬,但仅少数愿意考虑对乙酰氨基酚。

该横断面研究采用直接选择实验,于2021年3月3日至2022年2月10日通过两阶段虚拟视频访谈,纳入40名参与者(31名早产儿父母和9名早产儿成年者),评估他们对预防性使用吲哚美辛、布洛芬和对乙酰氨基酚的价值观与偏好。死亡(中位评分100)和严重脑室内出血(中位评分90.0)被评为最重要的两个不良结局。当仅提供一种药物时,多数参与者愿意考虑预防性吲哚美辛(36/40,90.0%)或布洛芬(34/40,85.0%),但仅4/40(10.0%)愿意考虑对乙酰氨基酚。在最初选择吲哚美辛的36人中,若同时提供预防性氢化可的松且两者不能同时使用,仅12/36(33.3%)仍偏好吲哚美辛。三种环氧合酶抑制剂均可用时,偏好存在变异性,吲哚美辛最受偏好(19/40,47.5%),其次为布洛芬(16/40,40.0%),其余5/40(12.5%)选择不预防。

要点

  • 死亡(中位评分100)和严重脑室内出血(中位评分90.0)被参与者评为最重要的两个不良结局。
  • 当仅提供一种药物时,36/40(90.0%)愿意考虑预防性吲哚美辛,34/40(85.0%)愿意考虑布洛芬,仅4/40(10.0%)愿意考虑对乙酰氨基酚。
  • 在最初选择吲哚美辛的36人中,若提供预防性氢化可的松且不能与吲哚美辛同时使用,仅12/36(33.3%)仍偏好吲哚美辛。
  • 三种环氧合酶抑制剂均可用时,19/40(47.5%)首选吲哚美辛,16/40(40.0%)首选布洛芬,5/40(12.5%)选择不预防。
  • 参与者对主要结局的价值观变异性很小,但对环氧合酶抑制剂的选择存在变异性。

适用人群与场景

  • 纳入人群:胎龄<32周的早产儿成年者,或当前在新生儿重症监护病房(NICU)的早产儿父母,或过去5年内从NICU出院的早产儿父母。
  • 研究场景:虚拟视频访谈,非急诊或ICU床旁决策场景。

研究设计与关键结果

  • 研究设计:横断面研究,采用直接选择实验,于2021年3月3日至2022年2月10日通过两阶段虚拟视频访谈进行(第一阶段为试点可行性研究,第二阶段为正式价值观与偏好研究),使用预定义便利样本。
  • 样本量:共44名参与者入组,40名纳入正式研究(31名父母和9名早产儿成年者);参与者或其子女出生时中位胎龄为26.0周(IQR 25.0-28.8)。
  • 主要结局评分:死亡中位评分100(IQR 100-100),严重脑室内出血中位评分90.0(IQR 80.0-100)。
  • 仅提供一种药物时:愿意考虑预防性吲哚美辛36/40(90.0%),布洛芬34/40(85.0%),对乙酰氨基酚4/40(10.0%)。
  • 在最初选择吲哚美辛的36人中,若提供预防性氢化可的松且两者不能同时使用,仅12/36(33.3%)仍偏好吲哚美辛。
  • 三种环氧合酶抑制剂均可用时:首选吲哚美辛19/40(47.5%),首选布洛芬16/40(40.0%),选择不预防5/40(12.5%)。

证据类型、等级与局限

  • 证据类型:横断面研究(直接选择实验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,参与者对主要结局的价值观变异性很小,死亡和严重脑室内出血被评为最重要的两个不良结局。
  • 作者认为,吲哚美辛是最受偏好的预防形式,但当向参与者呈现每种药物的获益和危害时,环氧合酶抑制剂的选择存在变异性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: There is wide variability in the use of prophylactic cyclooxygenase inhibitor (COX-I) drugs to prevent morbidity and mortality in preterm infants. Parents of preterm infants are rarely involved in this decision-making process.

OBJECTIVE: To explore the health-related values and preferences of adults who were preterm infants and families of preterm infants concerning the prophylactic use of indomethacin, ibuprofen, and acetaminophen initiated within the first 24 hours after birth.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used direct choice experiments conducted in 2 phases of virtual video-conferenced interviews between March 3, 2021, and February 10, 2022: (1) a pilot feasibility study and (2) a formal study of values and preferences, using a predefined convenience sample. Participants included adults born very preterm (gestational age <32 weeks) or parents of very preterm infants currently in the neonatal intensive care unit (NICU) or having graduated from the NICU in the last 5 years.

MAIN OUTCOMES AND MEASURES: Relative importance of clinical outcomes, willingness to use each of the COX-Is when presented as the only option, preference for using prophylactic hydrocortisone vs indomethacin, willingness to use any of the COX-Is when all 3 options are available, and relative importance of having family values and preferences included in decision-making.

RESULTS: Of 44 participants enrolled, 40 were included in the formal study (31 parents and 9 adults born preterm). The median gestational age of the participant or the participant's child at birth was 26.0 (IQR, 25.0-28.8) weeks. Death (median score, 100 [IQR, 100-100]) and severe intraventricular hemorrhage (IVH) (median score, 90.0 [IQR, 80.0-100]) were rated as the 2 most critical outcomes. Based on direct choice experiments, most participants were willing to consider prophylactic indomethacin (36 [90.0%]) or ibuprofen (34 [85.0%]), but not acetaminophen (4 [10.0%]) when offered as the only option. Among participants who initially chose indomethacin (n = 36), if prophylactic hydrocortisone was offered as a potential therapy with the caveat that both cannot be used simultaneously, only 12 of 36 (33.3%) preferred to remain with indomethacin. Variability in preference was noted when all 3 COX-I options were available, indomethacin (19 [47.5%]) being the most preferred option followed by ibuprofen (16 [40.0%]), while the remainder opted for no prophylaxis (5 [12.5%]).

CONCLUSIONS AND RELEVANCE: The findings of this cross-sectional study of former preterm infants and parents of preterm infants suggest that there was minimal variability in how participants valued the main outcomes, with death and severe IVH being rated as the 2 most important undesirable outcomes. While indomethacin was the most preferred form of prophylaxis, variability was noted in the choice of COX-I interventions when participants were presented with the benefits and harms of each drug.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Mitra S, Hatfield T, Campbell-Yeo M, et al. Evaluation of Health-Related Values and Preferences of Adults Who Were Preterm Infants and Parents of Preterm Infants Concerning Use of Prophylactic Cyclooxygenase Inhibitor Drugs. JAMA Netw Open. 2023. PMID: 36892840. doi:10.1001/jamanetworkopen.2023.2273

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。